Articles from Sermo

The 38th Barometer from Sermo, a fast, frictionless HCP engagement platform providing the healthcare industry with real-time business insights and authentic physician touch points, found that while physician burnout hit its peak during the COVID-19 pandemic, many physicians are still actively experiencing burnout with 75% of reporting they have seen a colleague experience burnout in the past three months.

The 37th Barometer from Sermo, a fast, frictionless HCP engagement platform providing the healthcare industry with real-time business insights and authentic physician touch points, found that 81% of physicians believe technical proficiency is as important as clinical expertise in their practices. This underscores the growing role of technology in enabling more efficient and accurate care.

The 36th Barometer from Sermo, a fast, frictionless HCP engagement platform providing the healthcare industry with real-time business insights and authentic physician touch points, revealed that 78% of U.S. physicians feel health insurance companies have too much influence in determining which treatments and procedures are approved for patients; this declines to 52% globally and 38% in Europe.

The 35th Barometer from Sermo, a fast, frictionless HCP social engagement platform and leader in healthcare insights, revealed that healthcare providers (HCPs) are most eager to see GLP-1 medications be approved to treat sleep apnea. The Barometer surveyed 1,150+ global healthcare providers across specialties on their experience prescribing weight loss medications. In addition to sleep apnea, HCPs were most interested in seeing GLP-1 medications approved to treat chronic heart failure and MASH (formerly NASH).

The 34th Barometer from Sermo, an online physician and provider community and leader in healthcare insights, surveyed 430+ mental healthcare providers around the world, including psychiatrists, general practice physicians, and advanced practice providers, on their sentiments about psychedelic and dissociative drug treatments, finding that 94% would be open to integrating these treatments into their practices if legalized in their countries. Worldwide, there has been growing interest from industry, government, media, and patients in psychedelics for the treatment of mental health conditions. 89% of HCPs surveyed believe that psychedelic medicines have unique therapeutic potential compared to traditional medications in treating patients with significant mental health conditions, such as treatment-resistant depression, post-traumatic stress disorder, and anorexia nervosa.

Run for Research, an annual global connected run to raise money for life-saving medical research, proudly announces a $500,000 donation to support medical research after reaching a milestone 10,000+ registrants for the event on June 9th. In the first two years, Run for Research was a physician-led initiative and this year, the run was opened to all runners who want to support life-saving medical innovation. Runners around the globe pledged a distance and chose a medical cause; every 1,000 runners registered unlocked a $100,000 donation from Sermo, up to $500,000. This past Sunday, Run for Research activated 10,160 total runners of which over 9,000 physician runners, spanning 86 countries and over 71,000km.

The 32nd Barometer survey from Sermo, an online physician and provider community and leader in healthcare insights, of 100+ U.S. healthcare decision-makers working in hospitals or healthcare facilities found that while interest in AI and machine learning is high, they have a long way to go to leverage it successfully. Nearly half (45%) of these executives report they are actively following trends in AI and machine learning in the industry, yet only 25% have implemented AI/machine learning in their organization. 1 in 5 (21%) of surveyed healthcare leaders feel that significant opportunities are being missed to implement emerging AI applications.

The 31st Barometer survey from Sermo, a physician-first online community and leader in HCP insights, of 300+ global practitioners revealed that 77% of HCPs feel that celebrities and influencers’ enthusiasm for prescription medications for weight loss or a weight loss benefit causes patients to have unrealistic expectations of the medications.

Peter Kirk, CEO of Sermo and Founder of Be Your Possible, has been named a PharmaVoice 100 honoree. This annual list recognizes the most inspiring people in the life sciences industry. Peter is included for his work and commitment to raise $1 million for medical research by running 1,000 half-marathons before the 10th anniversary of his blood stem cell transplant. Be Your Possible’s mission to inspire others and fundraise for research was born from Kirk’s own harrowing experience of surviving Acute Myeloid Leukemia. The flagship event of the organization is his annual fundraiser “Run with Peter,” in which physicians choose to run or walk for a medical organization of their choice. To date, the organization has raised more than $350,000 for medical research.

A new survey from Sermo, a physician-first online community and leader in HCP insights, of 300+ oncologists revealed they would like an average of seven more minutes per appointment explaining treatment plans to improve the patient experience. On average oncologists reported spending 27.5 minutes with patients explaining treatment plans, however, in an ideal world, oncologists wish they could spend 34 minutes with patients.

A new survey from Sermo, a physician-first online community and leader in HCP insights, of 300+ Dermatology-focused physicians found there is significant apprehensiveness about cosmetic content they are seeing on consumer-facing social media as 74% of physicians agreed they have safety concerns about cosmetic trends they have seen or heard about on TikTok and other social platforms. 59% of the physicians surveyed feel that social media has hurt the effort to manage patients' expectations with cosmetic treatments.

A new joint survey from Sermo and LiveWorld found that 57% of U.S.-based physicians frequently or occasionally change their perception of a medication or treatment based on content they’ve seen on social media. Only 16% of surveyed physicians reported that their perceptions have never been influenced by social media. This change in perception driven by social media often leads physicians to change their prescribing habits as reported by 41% of surveyed physicians. Pharma marketers increasingly understand the value of social media influence and are invested in the future of social media in their marketing budgets. In the survey targeted to pharma marketers, 94% of respondents said that social media is an important HCP channel.

A new survey from Sermo, a physician-first online community and leader in HCP insights, of 1,200+ global physicians found that optimism is high for the future of mRNA technology for patient treatments. Physicians across all 14 specialties surveyed were in agreement that mRNA technology will have a future role in healthcare beyond Covid-19, as 76% reported they would prescribe mRNA technology treatments once available. Physicians were also in agreement that oncology is the therapeutic area with the most to benefit from the technology. While clinical excitement is high, physicians were widely in agreement that patient adoption will be a challenge due to misinformation about the technology steaming from the pandemic. 61% of physicians surveyed felt that patients will be hesitant to accept new mRNA technology due to the polarization of the Covid-19 vaccine.

Timed to World AIDS Day, Sermo, a physician-first online community and leader in global HCP insights, released a new survey that found 46% of general care physicians including PCPs, OB-GYNs, and pediatric physicians, reported they feel they do not have enough knowledge about currently approved PrEP medication options to prescribe them to patients. Whereas 98% of infectious disease specialists reported they felt they have enough knowledge about PrEP medications signaling a need for further education from industry stakeholders for noninfectious disease specialists. An important area of opportunity as patients who are likely good candidates for PrEP often go to a PCP instead of seeking out an infectious disease specialist.

A new survey from Sermo, a physician-first online community and leader in global HCP insights, found that the majority of physicians feel there is a lack of clinical guidelines to diagnose and treat Long Covid in patients in their practices. The survey of more than 1,100 global physicians found that 86% felt there is a lack of clinical guidance on how to diagnose Long Covid and 87% reported that they felt there is a lack of clinical guidance on how to treat Long Covid in patients.

With the spread of monkeypox on the rise and the World Health Organization (WHO) declaring a global health emergency, findings from a recent survey conducted by Sermo, a physician-first online community and leader in global HCP insights, show there is high concern about public misinformation spreading. The survey also found that while 71% of respondents would recommend vaccination as a preventative measure to a patient who was concerned about contracting monkeypox, 65% of doctors say their country does not have enough vaccines.

Sermo CEO Peter Kirk announces today the successful completion of the first-ever global, doctor-led running event, Run with Peter-Run for Research. Run With Peter is an initiative to empower and inspire a global community of physicians, healthcare teams and partners who run (or walk) together to raise money in support of medical research. This year, the event was held on June 12th with physician runners participating globally from 75 countries, pledging to run 33,073 kilometers.

A new survey from Sermo, a physician-first online community and leader in global HCP insights, timed to the annual American Society of Clinical Oncology (ASCO) conference found that nearly half (47%) of attending oncologists are most interested in new data being presented about lung cancer. This is followed by a similarly high interest in new data about breast cancer, as reported by 44% of oncologists surveyed. Additionally, oncologists/hematologists reported they are most excited about learning about tumor targeting antibodies treatments as reported by 54% of those surveyed.

Sermo CEO Peter Kirk announces today the launch of the first-ever global, doctor-led running event, “Run with Peter” to raise $2 million for medical research. Run With Peter is an initiative to empower and inspire a global community of physicians, healthcare teams and partners who run together to raise money in support of medical research.

A new survey from Sermo, a physician-first online community and leader in global HCP insights, found that physicians are facing a challenging onslaught of COVID-19 vaccine and treatment misinformation as reported by 3,600+ doctors around the world.

In a slight departure from Sermo’s dive into physicians thoughts on COVID this year, Sermo conducted its first Holiday Survey tapping into 2,591 Sermo physicians across 26 countries to gather their opinions on the most pressing scientific and medical questions surrounding Santa Claus, Rudolph the Red-Nosed Reindeer, the Holidays and New Year’s traditions. Sermo conducted the survey of their physician community in November 2021.

Sermo’s most recent COVID-19 Real Time Barometer surveyed 3,050 physicians across 26 countries and showed that while more physicians are hearing fewer concerns from patients about the side effects of the vaccine now (59%) compared to six months ago (72%), more physicians are reporting patients are coming to them with vaccine misinformation vs. six months ago. Specifically, in our June study (n=3,050 physicians, 24 countries), 45% of doctors said their patients shared misinformation expressing concerns about one or more of the following vs. 53% in our most recent poll:

True North, a global prostate cancer website created by Movember, the leading charity focused on men's health, has partnered with Sermo to provide physicians with enhanced resources for their prostate cancer patients. The partnership offers doctors and other HCPs on the Sermo platform access to True North’s educational content and tools pertaining to men’s health and prostate cancer.

Almost seventy-five percent of physicians have seen an increase in COVID cases among children, mostly due to the Delta variant, with 45% of physicians seeing the greatest increase among children aged 5-12 years, a new global survey of 1,528 physicians finds.

With variants on the rise and the continued need for vaccinations, a new global survey of physicians finds that many doctors believe that they may be the key to boosting vaccination rates as they are an important source of information, comfort, and reassurance for COVID-19 vaccine-reluctant patients. In Sermo’s most recent COVID-19 Real Time Barometer survey, nearly 70% of physicians said that if they could administer the vaccine to reluctant patients themselves, they believe patients would feel more comfortable about getting vaccinated. Additionally, nearly half of physicians surveyed said that their ability to discuss the benefits of vaccination and answer patient’s questions during appointments could help increase patients’ willingness to get vaccinated.

Sermo, the world’s leading HCP insights company and the first social media platform for physicians, today announced its acquisition of Australia-based market research leader, Minter Group. The acquisition expands Sermo’s existing panel of 1.3M physicians to include an additional 50,000+ Asia-Pacific (APAC)-based HCPs, and aims to better connect the pharmaceutical industry to HCPs in emerging markets.

Today, Sermo -- a social platform for peer-to-peer physician collaboration and frontline information sharing -- announced a partnership with Bionical Solutions - a leading provider of technology enabled engagement and healthcare services -- to bring Bionical Solutions’ engagement platform to Sermo’s 800,000+ physician members. The partnership provides physicians around the world the ability to customize, personalize, and regionalize educational resources to help create actionable treatment plans for their patients with the goal of driving behavior change, and more importantly, better patient outcomes.

As the rate of people receiving COVID-19 vaccinations has slowed, a new survey of physicians has revealed that doctors are working hard to combat vaccine hesitancy, even among those who have already received their first dose. More than 72% of physicians surveyed said that patients continue to voice concerns over vaccine side effects. Still, others have reported ongoing misinformation discouraging people from getting vaccines. In addition, close to 30% of physicians reported encountering patients who have skipped their second dose due to unpleasant side effects of the first dose, or concerns over side effects.